StratDeckJNJ

Johnson & Johnson

JNJ✓
Share

Healthcare · Drug Manufacturers - General · United States

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Price266.32USD
1D+0.28%
Market cap642B
AnalystsBuy22
Next earnings13 Oct
Loading chart…

Trade ideas

JNJ isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusBuy22
Mean score1.91
Mean target277.91+4.35%
Target range190.00–320.00

Value vs sector peers

#22 of 26 in HealthcareWeakest in sector24
  • Fwd P/E21.520
  • P/B7.523
  • Yield2.0%26
  • P/E30.933
  • Rev growth+6.6%44

Nearest in Healthcare

  1. #20DHRDanaher CorporationWeakest in sector32
  2. #21MCKMcKesson CorporationPaying up for quality29
  3. #22JNJJohnson & JohnsonWeakest in sector24
  4. #23TMOThermo Fisher Scientific Inc.Paying up for quality23

Fundamentals

P/E30.9
Forward P/E21.5
Price / book7.55
Dividend yield2.02%
Beta0.23
52-week range173.33–281.0786/100
ADV (USD)1.68B
Relative volume0.8
10d avg volume6.07M
Revenue growth+6.60%
EPS growth-0.90%

Performance

1D+0.28%
7D-3.24%
1M+2.29%
3M+13.01%
6M+10.14%
YTD+30.12%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named JNJ.

Catalysts

Next earnings: 13 Oct

Trade idea history

No trade idea has fired on JNJ since the ledger opened.

Get it by email

The board JNJ sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.